AVH News & Analysis

In a listener requested episode, we speak about whether small caps have a place in your portfolio. 

A return to normal has increased the incidence of burns and that means business for the spray-on-skin maker.

Morningstar is looking past the reported net loss to increased use of the company’s flagship spray-on skin therapy.

The corona sell-off hurt the spray-on-skin maker but it’s got an eye on the bigger picture, says Nicolette Quinn

Spray-on-skin maker Avita has had runaway success on the ASX. And it's not done yet, says Morningstar's Nicolette Quinn.